Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment
- 1 October 2016
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Diabetes
- Vol. 40 (5), 449-454
- https://doi.org/10.1016/j.jcjd.2016.03.002
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The clinical utility of C‐peptide measurement in the care of patients with diabetesDiabetic Medicine, 2013
- Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the YoungDiabetes Care, 2012
- The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetesDiabetologia, 2012
- Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 DiabetesDiabetes Care, 2011
- Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 DiabetesDiabetes Care, 2011
- Assessment of High-Sensitivity C-Reactive Protein Levels as Diagnostic Discriminator of Maturity-Onset Diabetes of the Young Due to HNF1A MutationsDiabetes Care, 2010
- Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutationsActa Endocrinologica, 2010
- Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian ChildrenDiabetes Care, 2010
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A GenePLoS Medicine, 2007